Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications

Autor: Paulino A. Alvarez, Brett W. Sperry, Antonio L. Pérez, Dmitry M. Yaranov, Varinder Randhawa, Jacob Luthman, Daniel J. Cantillon, Randall C. Starling

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 14 (2019)

Background The effect of implantable cardioverter defibrillators (ICD) in patients with continuous flow left ventricular assist devices (LVADs) on outcomes has not been evaluated in a randomized clinical trial. Methods and Results This is a retrospec

Externí odkaz: https://doaj.org/article/15b8f099b18a4c84a2fd5139c4ae0556

Contributors

Autor: Masood Akhtar, William R. Auger, Richard G. Bach, Raquel R. Bartz, Eric R. Bates, Brigitte M. Baumann, Richard C. Becker, Dmitri Belov, Andreia Biolo, Daniel Blanchard, David L. Brown, Clifton W. Callaway, Matthew J. Chung, Richard F. Clark, Wilson S. Colucci, Leslie T. Cooper, Harold L. Dauerman, Elyse Foster, Stephanie Gaydos, Mark Gdowski, Timothy Gilligan, Michael M. Givertz, Prospero B. Gogo, Sarah J. Goodlin, Barry Greenberg, David Gregg, George Gubernikoff, Colleen Harrington, Nazish K. Hashmi, Alan C. Heffner, Bettina Heidecker, Maureane Hoffman, Brian D. Hoit, Ruth Hsiao, Robert C. Hyzy, Jacob C. Jentzer, Joyce Ji, Lauren H. Jones, Ulrich Jorde, Rochelle Judd, Jason N. Katz, Mohamad Kenaan, Briana N. Ketterer, Holly Keyt, Jon A. Kobashigawa, Richard Koch, Sándor J. Kovács, Alexander Kuo, Milla J. Kviatkovsky, A. Michael Lincoff, Mark S. Link, Jacob Luthman, Judith A. Mackall, Rohit Malhotra, Pamela K. Mason, Jason Matos, Sharon McCartney, Theo E. Meyer, Alicia Minns, Joshua D. Mitchell, Narain Moorjani, Jonathan D. Moreno, Michael S. O'Connor, Marlies Ostermann, Demosthenes G. Papamatheakis, Nimesh Patel, Richard M. Pescatore, Jay I. Peters, Abhiram Prasad, Susanna Price, Thomas M. Przybysz, Claudio Ronco, Michael Shehata, Jeffrey A. Shih, Daniel M. Shivapour, Adam Shpigel, Bryan Simmons, Daniel B. Sims, Hal A. Skopicki, Martin L. Smith, Burton E. Sobel, Nishtha Sodhi, Ali A. Sovari, Dina M. Sparano, Peter C. Spittell, Christie Sun, Roderick Tung, Peter D. Wagner, Daniel E. Westerdahl, Ryan E. Wilson, Jonathan D. Wolfe, Paria Zarghamravanbakhsh, Shoshana Zevin, Khaled M. Ziada, Jodi Zilinski, Peter Zimetbaum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61d8a2fdc1f655e508d412558d60dcc8
https://doi.org/10.1016/b978-0-323-52993-8.00071-0

Sacubitril-Valsartan Initiation Post-Left Ventricular Assist Device is Safe and Effective

Autor: Randall C. Starling, Varinder K. Randhawa, Edward G. Soltesz, Jacob Luthman, Lucianne M. West, Jerry D. Estep

Publikováno v: Journal of Cardiac Failure. 25:S62

Introduction and Aim Guideline-directed medical therapy for heart failure (HF) with reduced ejection fraction includes demonstrated benefit from the combination drug sacubitril-valsartan in acute and chronic heart failure. However, little is known of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::82e6a50c0d6a85b885020f466f524d5b
https://doi.org/10.1016/j.cardfail.2019.07.176